Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC554316852;16853;16854 chr2:178732342;178732341;178732340chr2:179597069;179597068;179597067
N2AB522615901;15902;15903 chr2:178732342;178732341;178732340chr2:179597069;179597068;179597067
N2A429913120;13121;13122 chr2:178732342;178732341;178732340chr2:179597069;179597068;179597067
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCC
  • RefSeq wild type template codon: CGG
  • Domain: Ig-39
  • Domain position: 1
  • Structural Position: 1
  • Q(SASA): 0.2312
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T rs1460498518 -1.394 0.98 N 0.507 0.266 0.173771789658 gnomAD-2.1.1 3.19E-05 None None None None N None 1.14863E-04 0 None 0 0 None 0 None 0 0 0
A/T rs1460498518 -1.394 0.98 N 0.507 0.266 0.173771789658 gnomAD-3.1.2 6.57E-06 None None None None N None 2.41E-05 0 0 0 0 None 0 0 0 0 0
A/T rs1460498518 -1.394 0.98 N 0.507 0.266 0.173771789658 gnomAD-4.0.0 6.57445E-06 None None None None N None 2.41429E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.8015 likely_pathogenic 0.8006 pathogenic -1.528 Destabilizing 1.0 D 0.558 neutral None None None None N
A/D 0.9666 likely_pathogenic 0.9712 pathogenic -1.946 Destabilizing 0.994 D 0.557 neutral N 0.480949416 None None N
A/E 0.949 likely_pathogenic 0.9523 pathogenic -1.974 Destabilizing 0.985 D 0.518 neutral None None None None N
A/F 0.9451 likely_pathogenic 0.944 pathogenic -1.333 Destabilizing 0.999 D 0.625 neutral None None None None N
A/G 0.4414 ambiguous 0.4732 ambiguous -1.214 Destabilizing 0.98 D 0.473 neutral N 0.480949416 None None N
A/H 0.9826 likely_pathogenic 0.9841 pathogenic -1.195 Destabilizing 1.0 D 0.63 neutral None None None None N
A/I 0.6657 likely_pathogenic 0.6598 pathogenic -0.558 Destabilizing 0.999 D 0.568 neutral None None None None N
A/K 0.9843 likely_pathogenic 0.9853 pathogenic -1.141 Destabilizing 0.985 D 0.52 neutral None None None None N
A/L 0.6324 likely_pathogenic 0.6138 pathogenic -0.558 Destabilizing 0.985 D 0.508 neutral None None None None N
A/M 0.7843 likely_pathogenic 0.7848 pathogenic -0.642 Destabilizing 1.0 D 0.573 neutral None None None None N
A/N 0.939 likely_pathogenic 0.9455 pathogenic -1.113 Destabilizing 0.999 D 0.601 neutral None None None None N
A/P 0.1987 likely_benign 0.1983 benign -0.669 Destabilizing 0.011 N 0.342 neutral N 0.261064087 None None N
A/Q 0.9511 likely_pathogenic 0.9532 pathogenic -1.362 Destabilizing 0.999 D 0.575 neutral None None None None N
A/R 0.9644 likely_pathogenic 0.9658 pathogenic -0.771 Destabilizing 0.999 D 0.576 neutral None None None None N
A/S 0.2742 likely_benign 0.3007 benign -1.419 Destabilizing 0.98 D 0.486 neutral N 0.481296132 None None N
A/T 0.3578 ambiguous 0.3878 ambiguous -1.363 Destabilizing 0.98 D 0.507 neutral N 0.481989566 None None N
A/V 0.3001 likely_benign 0.3047 benign -0.669 Destabilizing 0.98 D 0.503 neutral N 0.46392388 None None N
A/W 0.9936 likely_pathogenic 0.9939 pathogenic -1.592 Destabilizing 1.0 D 0.668 neutral None None None None N
A/Y 0.9781 likely_pathogenic 0.9789 pathogenic -1.172 Destabilizing 0.999 D 0.625 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.